Senior insider sale
Chief Financial Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$114.5K
29.67K shares
What this filing means
JORGENSEN NATHAN D. plans to sell 29.67K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $114.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001959173-26-003666
Officer· Chief Financial Officer
Since Feb 2026
29.67K
Shares to sell
$114.5K
Approx. market value
25K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/21/2026
6KRestricted Stock Vesting
Compensation
10/1/2025
19KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/21/2026 | Restricted Stock Vesting Compensation | 6K | — |
10/1/2025 | Restricted Stock Vesting Compensation | 19K | — |
| Total | 25K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.67K
Market value
$17.6K
2/24/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
25K
Market value
$96.9K
5/15/2026
Total
Units
29.67K
Value
$114.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/24/2026 | 4.67K | $17.6K | — | Completed |
| Planned — Approximate Date | ||||
5/15/2026 | 25K | $96.9K | NASDAQ | Planned |
| Total | 29.67K | $114.5K | ||